Samuel Martel

Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2–positive early breast cancer: Analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials

Matteo Lambertini, Samuel Martel, Christine Campbell et al. · Cancer · 2018 · 72 citations · Full text

Medicine, Obstetrics, Oncology +17

Impact of body mass index on the clinical outcomes of patients with HER2-positive metastatic breast cancer

Samuel Martel, Elena Poletto, Arlindo R. Ferreira et al. · The Breast · 2017 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +16

Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial

Jeanne Tie, Yuxuan Wang, Jonathan M. Loree et al. · Nature Medicine · 2025 · 39 citations

Medicine, Oncology, Gastrointestinal Oncology +16

Body Mass Index and Weight Change in Patients With HER2-Positive Early Breast Cancer: Exploratory Analysis of the ALTTO BIG 2-06 Trial

Samuel Martel, Matteo Lambertini, Dominique Agbor‐Tarh et al. · Journal of the National Comprehensive Cancer Network · 2021 · 27 citations · Full text

Medicine, Oncology, Breast Oncology +13

Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer

Christian Maurer, Arlindo R. Ferreira, Samuel Martel et al. · The Breast · 2018 · 13 citations · Full text

Medicine, Oncology, Pharmacology +16